AzTrials
AzTrials

Premenstrual SyndromeNCT07074314

The Effect of Laughter Yoga and Premenstrual Symptoms

A study testing Laughter yoga in people with Premenstrual Syndrome and Quality of Life, run by Kırklareli University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Premenstrual Syndrome (PMS) describes somatic, cognitive, emotional, and behavioral symptoms that occur in women during the luteal phase of the menstrual cycle and resolve with the onset of menstruation. These symptoms are common during the reproductive years. Read more about this study

Who is it for?
Ages 18 to 25 years, women onlyHealthy volunteers can take part
Conditions the study is for
Premenstrual Syndrome, Quality of Life
What is being tested?
Laughter yoga
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
1 siteTurkey (Türkiye)
Study dates
25 Dec 2025to 30 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Volunteering to participate in the research
  • Fully answering survey and scale forms
  • Ability to read and understand Turkish
  • Being between the ages of 18 and 25 years
  • Having regular menstruation (between 21 and 35 days)

Who cannot join

  • Unwilling to continue working
  • Having any problem that prevents communication (such as hearing, speaking, and understanding abilities),
  • Having a gynecological disease (abnormal uterine bleeding, uterine fibroids, ovarian cysts, hormonal treatment, etc.)
  • Having a chronic or physical illness
  • Having a mental illness
  • Being under psychiatric treatment (Pharmacotherapy or psychotherapy)
  • Taking medication for menopausal symptoms
  • Using one of the pharmacological or non-pharmacological methods to reduce premenstrual symptoms (COCs, acupressure, homeopathy, etc.)

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Cukurova University

    Adana

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Laughter Yoga on Quality of Life and Premenstrual Symptoms in Young People With Premenstrual Syndrome: A Randomized Controlled Experimental Study

Premenstrual Syndrome (PMS) describes somatic, cognitive, emotional, and behavioral symptoms that occur in women during the luteal phase of the menstrual cycle and resolve with the onset of menstruation. These symptoms are common during the reproductive years. The emotional symptoms of PMS include depression, outbursts of anger, irritability, crying spells, anxiety, confusion, social withdrawal, poor concentration, insomnia, increased short sleep, and changes in sexual desire. Premenstrual symptoms negatively impact women's relationships with family, work, and friends, as well as their social activities. Furthermore, premenstrual symptoms negatively impact a woman's quality of life, making them an important issue to address early in a woman's life. Numerous treatment methods are used to reduce or eliminate PMS symptoms. Laughter yoga is one of the alternative medicine methods that has recently emerged and is used to maintain and improve health. No studies have examined the effectiveness of laughter yoga in reducing premenstrual syndrome. This study aims to determine the effects of laughter yoga on quality of life and premenstrual symptoms in young people experiencing premenstrual syndrome.

Read the detailed description

Premenstrual Syndrome (PMS) describes somatic, cognitive, emotional, and behavioral symptoms that occur in women during the luteal phase of the menstrual cycle and resolve with the onset of menstruation. These symptoms are common during the reproductive years. The emotional symptoms of PMS include depression, outbursts of anger, irritability, crying spells, anxiety, confusion, social withdrawal, poor concentration, insomnia, increased short sleep, and changes in sexual desire. Physical symptoms include thirst, appetite changes, breast tenderness, bloating and weight gain, headaches, swelling in the hands or feet, aches and pains, fatigue, skin problems, and gastrointestinal symptoms, which can occur in the days before and after menstruation. While the epidemiology, etiology, and pathophysiology of PMS, first described in the literature in 1931, have not yet been fully elucidated, factors that may contribute to its development include thyroid dysfunction, hormonal changes, neurotransmitters, hypoglycemia, fluid retention, genetic and psychological factors, diet, stress, and lifestyle. Epidemiological studies indicate that PMS affects approximately one-fifth of women. Therefore, while PMS is common in adolescence and young adulthood, it stands out as a significant problem during this period. Premenstrual symptoms negatively impact women's relationships with family, work, and friends, as well as their social activities. They can lead to losses in education and employment, decreased work productivity, increased error/accident rates, alcohol/substance abuse, and criminal behavior, and negative mother-child behavior. It's also known that mental disorders and physical illnesses worsen during the premenstrual period, and psychiatric hospitalizations increase. Furthermore, premenstrual symptoms negatively impact a woman's quality of life, making them an important issue to address early in a woman's life. Numerous treatment methods are used to reduce or eliminate PMS symptoms.

The goal of treatment for PMS is to reduce or eliminate symptoms, reduce negative impacts on activities and relationships, and minimize treatment side effects. A stepwise approach should be implemented in PMS treatment, encompassing non-pharmacological treatment, pharmacological treatment, and surgical treatment. It has been reported that 60% of women with PMS symptoms seek treatment for their symptoms, but only about half as often seek medical attention.

Recommended non-pharmacological treatments include lifestyle changes, education, dietary support, herbal treatment options, acupuncture, and cognitive behavioral therapy. Lifestyle changes include regular exercise, limiting caffeine, salt, and alcohol consumption, eliminating nicotine, and increasing complex carbohydrate intake. Exercise has been shown to reduce PMS symptoms. Shifting focus is particularly important. Cognitive therapy methods and physical activity have been found to reduce PMS symptoms. Alternative medicine methods, in particular, are widely used to reduce PMS symptoms.

Laughter yoga is one of the alternative medicine methods that has recently emerged and is used to maintain and improve health. Laughter is generally considered a visual expression of happiness or a feeling of joy. It also helps clarify one's intentions in social interactions and foster emotional connection in conversations. Laughter is contagious; when a person laughs, the person next to them is often moved and begins to laugh as well. Laughter has been described as a universal phenomenon that can be observed in the body and contributes to irreplaceable social functions. During the emergence of laughter, people establish relationships between objects and attribute specific meanings to them by comparing them with others. The combination of all these factors provides relief. People laugh not only at humor, but also when solving a puzzle, escaping a dangerous situation, winning a game, experiencing disappointment, feeling hopeless, encountering an old friend, feeling embarrassed, or angry. Laughter can occur in a variety of emotional states. Laughter yoga has been found to lower cortisol levels, stabilize blood pressure, and improve quality of life scores, especially after the fourth session. Laughter yoga has been found to have a positive impact on young people's overall health, improving physical well-being and symptoms of sleep disorders, reducing anxiety and depression scores, and improving social functioning. In this context, considering the uses and benefits of laughter yoga, it is thought that it may be effective in reducing PMS symptoms. There are numerous studies in the literature on premenstrual syndrome. However, few studies have investigated the effectiveness of alternative methods for reducing symptoms. No studies have examined the effectiveness of laughter yoga in reducing premenstrual syndrome. This study aims to determine the effects of laughter yoga on quality of life and premenstrual symptoms in young people experiencing premenstrual syndrome.

Being tested
Laughter yoga
Keywords
laughter yoga, premenstraul syndrome, qualifty of life
Medical subject headings
Premenstrual Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laughter yogaOther

    Part 1: Deep Breathing Exercises: Raise the arms up towards the sky and take a deep breath as possible and hold the breath for 4-5 seconds. This application is repeated several times. This section takes approximately 5-10 minutes.

    Part 2: Warm-up exercises: Hands are kept parallel to each other and clapped. The tips of the fingers and palms touch each other, the acupuncture points on both hands are stimulated and the individual's energy level increases.

    Section 3: Childish Games: In this section there are childish games. These games are visualized in the mind and the participants are asked to raise their arms upwards in the shape of the letter "Y".This section takes approximately 10 minutes.

    Section 4: Laughter Exercises: Participants are given verbal guidance such as "Put your hand on your heart, feel your heartbeat, let's exhale with a smile, let's make a wish or pray" and the laughter exercise is terminated. This section takes approximately 15 minutes.

Study groups in NCT07074314
Study groupRoleWhat they receive
Laughter yoga groupExperimentalBefore starting the intervention, the researcher attended a 12-hour "Laughter Yoga Leader" course (8 hours of theory and 4 hours of Laughter Yoga Practice). Following the course, the researcher received a "Laughter Yoga" certificate. In the first stage, all participants will be asked to introduce themselves by giving their names and places of birth. Then, laughter yoga will begin with warm-up exercises and hand clapping movements. In the second stage, deep breathing exercises will be performed. After the deep breathing exercises, in the third stage, childlike games will be used to help induce laughter. In the final stage, laughter exercises will be conducted. Laughter yoga sessions will be conducted twice a week for 8 weeks, for a total of 16 sessions. Each session will be 30 minutes in duration.
Receives: Other: Laughter yoga
Control groupNo interventionParticipants in this group will consist of people who do not routinely do any practice on their own to reduce stress and burnout levels. The researcher will ask the participants via phone 4 times a week for 1 month whether they have taken any action to reduce their stress and burnout symptoms. Participants who use any of the pharmacological or non-pharmacological practices to reduce stress and burnout symptoms will be excluded from the study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Premenstrual Symptoms Coping Scale

    This scale assesses the coping with premenstrual symptoms in women aged 18-49. The scale consists of 27 items and five subscales in Turkish. Each item on this five-point Likert-type scale is scored from one to five. The total score is not used.

    Measured: between 2 to 4 weeks

  2. Premenstrual Syndrome-Specific Quality of Life Scale

    The scale consists of 22 items divided into three subscales: physical, emotional, and social. Reverse coding is used for all items, with a minimum score of 22 and a maximum score of 110.

    Measured: between 2 to 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2025
  2. Study start25 Dec 2025
  3. Primary completion25 Dec 2025
  4. Study completion30 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled trial
Masking
Single blind
Who is masked
Participant
Enrolment
75 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07074314
Sponsor's protocol ID
KırklareliAS-15
Status last verified
Jan 2026
First submitted
10 Jul 2025
Last updated
27 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Laughter yoga in people with Premenstrual Syndrome and Quality of Life, run by Kırklareli University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Premenstrual Symptoms Coping Scale (time frame: between 2 to 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in